FENC
FENNEC PHARMACEUTICALS INC.
Biological Products, (No Diagnostic Substances)- 売上
- $45m
- 時価総額
- $340m
株価 $9.94 · 100株 994円
FennecPharmaceuticalsIncは医薬品事業を展開する
| 期 | 23/12 | 24/12 | 25/12 |
|---|---|---|---|
| 売上 | $21m | $48m | $45m |
| 成長率 | — | 123.7% | ▲6.1% |
| 総利益 | $20m | $20m | $20m |
| 総利益率 | 94.1% | 42.1% | 44.8% |
| 販管費 | $12m | $18m | $19m |
| 販管費率 | 57.0% | 38.8% | 41.7% |
| 営利 | ▲$13m | $3m | ▲$6m |
| 営利率 | ▲60.1% | 5.4% | ▲14.1% |
| 純利益 | ▲$16m | ▲$0m | ▲$10m |
| PBR | — | — | 9.6 |
| PSR | 16.0 | 7.1 | 7.6 |
| PGPR | 17.0 | 17.0 | 17.0 |
| PER | — | — | — |
| ﾈｯﾄｷｬｯｼｭ | ▲$18m | $7m | $17m |
| EV/EBITDA | — | 129.4 | — |
| Rule of 40 | — | 129% | ▲20% |
| セールス効率 | — | 0% | 0% |
※Rule of 40は売上成長率＋営業利益率、セールス効率は売上総利益増加÷販管費増加（販管費増のときのみ）